| E-Folder |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Strategic Planning > Consultant Cites Job Hunting As A Way of Gathering Business Intelligence |
|
E-Folder - Consultant Cites Job Hunting As A Way of Gathering Business Intelligence
It’s not easy to get detailed, updated information about your competitors: their strengths, weaknesses, and According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product current practices; or about organizations that are engaging in certain endeavors that are relevant to what ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in you think you may be doing in the future. You can speak to their former employees and pore over every comm lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. nt about the
firms in the press and online, but still, you’re just getting a map. Maps, as you know, are here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe omewhat handy, but they aren’t the territory. There’s nothing quite as valuable as stepping onto that fore d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ign shore if you want to learn something about a different culture. But how can you get into organizations ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc to learn about them? One way is by proposing a joint venture and another is by applying for one of their a easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi vertised positions. In many cases, if you seem credible and sincere, and if you’re willing to pay for an a nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically rline ticket, they’ll throw their doors open to you. More important, they’ll tell you exactly what you want and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ to know about how they make their money, and the key practices that are most pertinent to doing it. I hav ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi done this several times, and I’m astonished how porous and transparent managers are willing to be. In one ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a case I learned a great deal about a certain area of consulting that I was able to capitalize on right away. dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod In another situation, I learned exactly how two survey companies operated, and this information helped me cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin to determine whether and how I wanted to enter those fields. Recently, I was developing a product line per tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen aining to a specific topic, and I discovered a company, not in my field, had some expertise in that area. M t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel one day visit became a customized tutorial. I asked to sit in on one of their training sessions and they ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust et me, and they told me a great deal that I found helpful. Of all of the ways to invest in your personal a y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products nd professional development, I cannot think of a more cost effective method. You’d probably be willing to . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ay up to several hundred dollars for a generic, watered down public seminar that only peripherally relates elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip o your needs. Why not take as much, or even less, and have someone teach you exactly what you need to know tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Managing Your Internet Business for Success Are You Running Too Many Poor Or Non-Productive Meetings?
|